Acesso livre
Acesso livre

Interesse Geral

Agência da União Europeia afirma que o foco deve ser sobre a oferta de vacinação inicial para todos, e não sobre as doses de reforço.

3 Set, 2021 | 12:50h

EU agency says to focus on vaccines first not booster shots – Associated Press

Ver também: European officials say COVID-19 booster isn’t urgent – CIDRAP


Opinião | “Os problemas em indicar o uso de máscaras por jovens estudantes são reais.”

3 Set, 2021 | 12:48h

The Downsides of Masking Young Students Are Real – The Atlantic

 

Comentário com réplica no Twitter (fio – clique para saber mais)

 


OMS afirma que está monitorando uma nova variante da Covid, chamada “mu”.

3 Set, 2021 | 12:45h

WHO says it is monitoring a new Covid variant called ‘mu’ – CNBC

Ver também:

What’s the Mu variant? And will we keep seeing more concerning variants? – The Conversation

WHO monitoring new coronavirus variant named ‘Mu’ – France 24

New ‘mu’ coronavirus variant could escape vaccine-induced immunity, WHO says – LiveScience

WHO monitoring new coronavirus variant named Mu – The Guardian


“Long COVID”: saúde física e mental de crianças e jovens não hospitalizados depois da infecção por SARS-CoV-2 – 1 em cada 7 crianças pode ainda ter sintomas 15 semanas depois da infecção.

3 Set, 2021 | 11:21h

Long COVID – the physical and mental health of children and non-hospitalised young people 3 months after SARS-CoV-2 infection; a national matched cohort study (The CLoCk) Study.

Comentários:

Long Covid in children ‘nowhere near scale feared’ – BBC

Long covid: One in seven children may still have symptoms 15 weeks after infection, data show – The BMJ

Conteúdos relacionados:

Do kids get long COVID? And how often? A pediatrician looks at the data – Children also get Long Covid, but much less often than adults.

Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents – “This study found a low prevalence of symptoms compatible with long COVID in a randomly selected cohort of children assessed 6 months after serologic testing”.

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

Cohort study: Risk factors for long covid in previously hospitalized children.

M-A: More than 50 long-term effects of COVID-19.

 

Comentário no Twitter (fio – clique para saber mais)

 


Outro estudo mostra redução da imunidade conferida pela vacina de mRNA da Pfizer ao longo do tempo.

3 Set, 2021 | 11:16h

Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar – medRxiv

Conteúdos relacionados:

[Press release – not published yet] Study shows vaccine protection wanes over time, but vaccines still offer good protection against severe disease.

Studies: COVID vaccine protection waning against infection but not hospitalization.

Pfizer says it’s time for a Covid booster; FDA and CDC say not so fast.

 

Comentário no Twitter (fio – clique para saber mais)

 


Por que a terceira dose de vacina contra COVID-19 é importante para pessoas imunocomprometidas?

2 Set, 2021 | 11:49h

Why is a third COVID-19 vaccine dose important for people who are immunocompromised? – The Conversation

Conteúdos relacionados:

FDA authorizes additional Covid-19 vaccine dose for certain immunocompromised individuals – Other fully vaccinated individuals do not need an additional vaccine dose right now.

RCT: third dose of Moderna mRNA vaccine increases immunity in transplant recipients.

Study: Among kidney transplant recipients who did not respond after 2 doses, a third dose of an mRNA-1273 vaccine induced a serologic response in 49% of patients.

Case series: Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients.


Perspectiva | Reforços da vacina contra COVID-19 em nações ricas atrasará a vacinação para todos.

2 Set, 2021 | 11:48h

COVID-19 boosters in rich nations will delay vaccines for all – Nature

 

Comentários no Twitter

 


Estudo demonstra imunogenicidade humoral significativamente mais alta induzida pela vacina da Moderna em comparação à vacina da Pfizer- BioNTech.

2 Set, 2021 | 11:28h

Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273 – JAMA

Conteúdos relacionados:

Moderna may be superior to Pfizer against Delta variant — breakthrough odds rise with time.

[Preprint] Pfizer vs. Moderna COVID-19 vaccine effectiveness against the Delta variant in Qatar – Effectiveness against symptomatic disease due to Delta was 53.5% for Pfizer and 84.8% for Moderna; effectiveness against severe disease due to Delta was 89.7% for Pfizer and 100.0% for Moderna.


Estudo mostra que as crianças ganharam peso durante a pandemia.

2 Set, 2021 | 11:22h

News release: Young children gained weight during the pandemic – Kaiser Permanente

Estudo original: Changes in Body Mass Index Among Children and Adolescents During the COVID-19 Pandemic – JAMA

 

Comentário no Twitter

 


Crianças têm “long COVID”? E com qual frequência? Um pediatra analisa os dados e conclui que crianças também têm “long COVID”, mas muito menos que os adultos.

2 Set, 2021 | 11:19h

Do kids get long COVID? And how often? A paediatrician looks at the data – The Conversation

Conteúdos relacionados:

Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents – “This study found a low prevalence of symptoms compatible with long COVID in a randomly selected cohort of children assessed 6 months after serologic testing”.

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

Cohort study: Risk factors for long covid in previously hospitalized children.

M-A: More than 50 long-term effects of COVID-19.


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.